Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://link.springer.com/chapter/10.1007/978-3-540-73677-6_8, but it redirected us to https://link.springer.com/chapter/10.1007/978-3-540-73677-6_8. The analysis below is for the second page.

Title[redir]:
Remyelination in Experimental Models of Toxin-Induced Demyelination | SpringerLink
Description:
Remyelination is the regenerative process by which demyelinated axons are reinvested with new myelin sheaths. It is associated with functional recovery and maintenance of axonal health. It occurs as a spontaneous regenerative response following demyelination in a...

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

πŸ™οΈ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 98,426,998 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We're unsure how the site profits.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {πŸ”}

google, scholar, pubmed, article, cas, remyelination, demyelination, blakemore, cns, franklin, oligodendrocyte, neurosci, cells, rjm, brain, cell, adult, spinal, cord, central, rat, neurol, system, multiple, sclerosis, experimental, neuropathol, nervous, chapter, lesions, demyelinated, transplantation, glia, neurobiol, zhao, progenitor, study, induced, oligodendrocytes, demyelinating, models, appl, gilson, crang, glial, exp, progenitors, schwann, pathol, axons,

Topics {βœ’οΈ}

lysophosphatidylcholine-induced macrophage activation month download article/chapter tnf-alpha promotes proliferation interleukin-1beta promotes repair bone marrow cells experimentally-induced demyelinating lesions chronic-stage multiple sclerosis common neural progenitor acute demyelinating/remyelinating lesion macrophage-depletion induced impairment post-mitotic oligodendrocytes incapable glial growth factor-2 gliotoxin-induced cns demyelination oligodendrocyte progenitor cell ludwin sk privacy choices/manage cookies demyelinated spinal cord oligodendrocyte progenitor cells demyelinated rat axons oligodendrocyte precursor cells smith kj oligodendrocyte progenitor recruitment immune-mediated models bone morphogenetic proteins rat spinal cord sim fj device instant download early inflammatory responses rabbit spinal cord central nervous system experimental demyelinating diseases woodruff rh myelinated axons demonstrated repair demyelinated lesions chronically demyelinated lesions kotter mr glial cell transplants cre-mediated recombination minocycline-mediated inhibition trapidil-mediated inhibition enhancing oligodendrocyte survival diphtheria toxin fragment adult rat cns cell depletion due adult human brain experimental demyelinating lesions ethidium bromide injection keirstead hs transplanted glial cells glial cell environments

Schema {πŸ—ΊοΈ}

ScholarlyArticle:
      headline:Remyelination in Experimental Models of Toxin-Induced Demyelination
      pageEnd:212
      pageStart:193
      image:https://media.springernature.com/w153/springer-static/cover/book/978-3-540-73677-6.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Advances in multiple Sclerosis and Experimental Demyelinating Diseases
         isbn:
            978-3-540-73677-6
            978-3-540-73676-9
         type:Book
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:W. F. Blakemore
            affiliation:
                  name:University of Cambridge
                  address:
                     name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. J. M. Franklin
            affiliation:
                  name:University of Cambridge
                  address:
                     name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      keywords:Experimental Autoimmune Encephalomyelitis, Schwann Cell, Myelin Sheath, Oligodendrocyte Progenitor Cell, Dorsal Funiculus
      description:Remyelination is the regenerative process by which demyelinated axons are reinvested with new myelin sheaths. It is associated with functional recovery and maintenance of axonal health. It occurs as a spontaneous regenerative response following demyelination in a range of pathologies including traumatic injury as well as primary demyelinating disease such as multiple sclerosis (MS). Experimental models of demyelination based on the use of toxins, while not attempting to accurately mimic a disease with complex etiology and pathogenesis such as MS, have nevertheless proven extremely useful for studying the biology of remyelination. In this chapter, we review the main toxin models of demyelination, drawing attention to their differences and how they can be used to study different aspects of remyelination. We also describe the optimal use of these models, highlighting potential pitfalls in interpretation, and how remyelination can be unequivocally recognized. Finally, we discuss the role of toxin models alongside viral and immune-mediated models of demyelination.
      datePublished:2008
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Advances in multiple Sclerosis and Experimental Demyelinating Diseases
      isbn:
         978-3-540-73677-6
         978-3-540-73676-9
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Cambridge
      address:
         name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge
      address:
         name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:W. F. Blakemore
      affiliation:
            name:University of Cambridge
            address:
               name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:R. J. M. Franklin
      affiliation:
            name:University of Cambridge
            address:
               name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
      name:Department of Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(346)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.88s.